Letter
NICE on spasticity
Authors’ reply to Crilly, and Willoughby and Graham
Cite this as:
BMJ
2012;345:e6679
- Moira A Mugglestone, director of guideline development1,
- Paul Eunson, consultant paediatric neurologist2,
- M Stephen Murphy, clinical co-director (children’s health)1
- On behalf of the Guideline Development Group
- 1National Collaborating Centre for Women’s and Children’s Health, London W1T 2QA, UK
- 2Royal Hospital for Sick Children, Edinburgh EH9 1LF, UK
- mmugglestone{at}ncc-wch.org.uk
Opinions differ on the place of selective dorsal rhizotomy in managing spasticity in children. In a recent debate in the House of Commons it was strongly advocated, as being “more robust than any other treatment for cerebral palsy.”1
We as guideline developers knew about the lack of high quality clinical evidence for the procedure, particularly in relation to important functional benefits and long term outcomes. We considered the three randomised controlled trials in the meta-analysis cited by Crilly. …
Sign in
Article access
Article access for 1 day
Purchase this article for £20 $30 €32*
The PDF version can be downloaded as your personal record
Social bookmarking